Aurinia Pharmaceuticals (AUPH) Treasury Shares (2020 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Treasury Shares came in at $1.8 million in Q1 2026, down 64.42% YoY from $4.9 million in Q1 2025, and down 56.4% on a QoQ basis from $4.0 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Treasury Shares (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Treasury Shares data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Treasury Shares fell 64.42% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 64.42% YoY) and the FY2025 annual result came in at $4.0 million, down 49.65% from the prior year.
- Treasury Shares retreated to $1.8 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $8.8 million in Q1 2024 to a low of $1.8 million in Q1 2026.
- A 5-year average of $5.5 million and a median of $4.9 million in 2025 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 470.61% in 2022, down 86.78% in 2022.
- Tracing AUPH's Treasury Shares over 5 years: stood at $2.0 million in 2022, then surged by 294.29% to $7.8 million in 2023, then gained by 2.29% to $8.0 million in 2024, then sank by 49.65% to $4.0 million in 2025, then slumped by 56.4% to $1.8 million in 2026.
- The last three Treasury Shares figures came in at $1.8 million (Q1 2026), $4.0 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 4.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.70 Mn |
| Jun 30, 2026 | 4.70 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Mar 31, 2025 | 4.93 Mn |
| Mar 31, 2025 | 4.93 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Mar 31, 2024 | 8.83 Mn |